AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33907293 — intervention group
Group type: EXPERIMENTAL
Intervention: fus-MRGB
Number of subjects: 199
Study 33907293 — intervention group
Group type: COMPARATOR
Intervention: cog-MRGB
Number of subjects: 199
Study 33099329 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 110
Study 33099329 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 110
Study 35801865 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored interventions (physical activity, cognitive behaviour therapy for insomnia, computerized memory training, cognitive behavioural therapy for self‐esteem)
Number of subjects: 142
Study 35801865 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 142
Study 35801865 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored interventions
Number of subjects: 142
Study 34022838 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help workbook intervention
Number of subjects: 200
Study 34022838 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 32112197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold snare polypectomy (CSP) for Ip polyps
Number of subjects: 634
Study 35619188 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (supervised aerobic and strength training 2 h/week, Nordic/power walking 2 h/week)
Number of subjects: 181
Study 35619188 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 181
Study 35619188 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 181
Study 34112840 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide bandwidth mechanical noise
Number of subjects: 0
Study 34112840 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow bandwidth mechanical noise
Number of subjects: 0
Study 34112840 — intervention group
Group type: COMPARATOR
Intervention: Control (no mechanical noise)
Number of subjects: 0
Study 32418881 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) - 6 sets/day, commencing 5 weeks before RP
Number of subjects: 97
Study 32418881 — intervention group
Group type: COMPARATOR
Intervention: Usual care PFMT - 3 sets/day
Number of subjects: 97
Study 35909305 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with additional adrenaline
Number of subjects: 40
Study 35909305 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine only
Number of subjects: 40
Study 32756479 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramadan intermittent fasting (RIF) for 30 days
Number of subjects: 30
Study 32756479 — intervention group
Group type: COMPARATOR
Intervention: Normal daily habits (Control Group)
Number of subjects: 30
Study 35595209 — intervention group
Group type: EXPERIMENTAL
Intervention: r-TEVAR
Number of subjects: 34
Study 35595209 — intervention group
Group type: COMPARATOR
Intervention: standard TEVAR
Number of subjects: 34
Study 32589342 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery incentives and motivational text messages
Number of subjects: 131
Study 32589342 — intervention group
Group type: COMPARATOR
Intervention: Motivational text messages only
Number of subjects: 131
Study 36152007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumescent local anaesthesia
Number of subjects: 782
Study 33153314 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom Observation Scale (13-item scale)
Number of subjects: 304
Study 33153314 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom Observation Scale (used by teachers and researchers)
Number of subjects: 304
Study 33153314 — intervention group
Group type: COMPARATOR
Intervention: Classroom Observation Scale (screen-positive children)
Number of subjects: 304
Study 32045411 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint training
Number of subjects: 32
Study 32045411 — intervention group
Group type: COMPARATOR
Intervention: Nordic training (NHE)
Number of subjects: 32
Study 32045411 — intervention group
Group type: COMPARATOR
Intervention: Soccer training
Number of subjects: 32
Study 34585396 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibudilast (50 mg, twice daily; n = 20)
Number of subjects: 45
Study 34585396 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 25)
Number of subjects: 45
Study 34585396 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibudilast (50 mg, twice daily)
Number of subjects: 45
Study 34585396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 36056577 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA <3 ng/mL
Number of subjects: 0
Study 36056577 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline PSA 0 to 0.99 ng/mL
Number of subjects: 0
Study 36056577 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline PSA 1.0 to 1.99 ng/mL
Number of subjects: 0
Study 36056577 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline PSA 2 to 2.99 ng/mL
Number of subjects: 0
Study 36056577 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA <1 ng/mL
Number of subjects: 0
Study 36056577 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA 2 to 2.99 ng/mL
Number of subjects: 0
Study 36056577 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescreening intervals based on PSA levels
Number of subjects: 0
Study 33908655 — intervention group
Group type: EXPERIMENTAL
Intervention: Reward Re-Training (RRT)
Number of subjects: 60
Study 33908655 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 60
Study 32105712 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-guided fine-needle biopsy (FNB)
Number of subjects: 229
Study 32105712 — intervention group
Group type: COMPARATOR
Intervention: EUS-guided fine-needle aspiration (FNA)
Number of subjects: 229
Study 37638240 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemopatch
Number of subjects: 315
Study 37638240 — intervention group
Group type: COMPARATOR
Intervention: Standard closure
Number of subjects: 315
Study 37638240 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemopatch (hand-sewn stump closure)
Number of subjects: 315
Study 37638240 — intervention group
Group type: COMPARATOR
Intervention: Standard closure (hand-sewn stump closure)
Number of subjects: 315
Study 37638240 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemopatch (main duct closure)
Number of subjects: 315
Study 37638240 — intervention group
Group type: COMPARATOR
Intervention: Standard closure (main duct closure)
Number of subjects: 315
Study 35924546 — intervention group
Group type: EXPERIMENTAL
Intervention: ropeginterferon alfa-2b
Number of subjects: 0
Study 35924546 — intervention group
Group type: COMPARATOR
Intervention: anagrelide
Number of subjects: 0
Study 32753545 — intervention group
Group type: EXPERIMENTAL
Intervention: TIL therapy
Number of subjects: 10
Study 36078633 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing free eyeglasses to students in poor provinces
Number of subjects: 0
Study 36078633 — intervention group
Group type: COMPARATOR
Intervention: Providing free eyeglasses to students in wealthier provinces
Number of subjects: 0
Study 32896456 — intervention group
Group type: EXPERIMENTAL
Intervention: qHBsAg <8 IU/mL in training set
Number of subjects: 359
Study 32896456 — intervention group
Group type: EXPERIMENTAL
Intervention: qHBsAg <8 IU/mL in validation set
Number of subjects: 359
Study 32896456 — intervention group
Group type: EXPERIMENTAL
Intervention: qHBsAg cutoff of 8 IU/mL
Number of subjects: 359
Study 32896456 — intervention group
Group type: EXPERIMENTAL
Intervention: qHBsAg cutoff of 200 IU/mL in training set
Number of subjects: 359
Study 32896456 — intervention group
Group type: EXPERIMENTAL
Intervention: qHBsAg in validation set
Number of subjects: 359
Study 32721845 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (20 mg/kg iv bolus before anesthesia induction followed by 20 mg/kg/h until surgery completion)
Number of subjects: 74
Study 32721845 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 74
Study 32456554 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable scaffolds (BRS)
Number of subjects: 0
Study 32456554 — intervention group
Group type: COMPARATOR
Intervention: First-generation Absorb
Number of subjects: 0
Study 34409931 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing integrated with cognitive behavioural therapy (MI-CBT)
Number of subjects: 49
Study 34409931 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT) alone
Number of subjects: 49
Study 33597586 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) (10 billion platelets)
Number of subjects: 150
Study 33597586 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA; 4 ml)
Number of subjects: 150
Study 33226107 — intervention group
Group type: EXPERIMENTAL
Intervention: Restored white pita bread (WP-R)
Number of subjects: 0
Study 33226107 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified white pita bread (WP-F)
Number of subjects: 0
Study 33226107 — intervention group
Group type: COMPARATOR
Intervention: Plain white pita bread (WP)
Number of subjects: 0
Study 35511592 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE, n = 10)
Number of subjects: 20
Study 35511592 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control (CTRL, n = 10)
Number of subjects: 20
Study 33982935 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention
Number of subjects: 0
Study 33982935 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34059848 — intervention group
Group type: EXPERIMENTAL
Intervention: Condoms (24%, n = 28/117)
Number of subjects: 275
Study 34059848 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive pill (22%, n = 26/117)
Number of subjects: 275
Study 32965797 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term water deprivation (WD)
Number of subjects: 7
Study 32965797 — intervention group
Group type: COMPARATOR
Intervention: Euhydration control condition
Number of subjects: 7
Study 33404379 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to anti-vaccine comments
Number of subjects: 1010
Study 33404379 — intervention group
Group type: COMPARATOR
Intervention: Mainstream news article discussing the flu vaccine
Number of subjects: 1010
Study 33995533 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest-to-back skin-to-skin contact (CB-SSC)
Number of subjects: 0
Study 33995533 — intervention group
Group type: COMPARATOR
Intervention: Chest-to-chest skin-to-skin contact (CC-SSC)
Number of subjects: 0
Study 32380894 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate metered dose inhaler (GP MDI) 18 μg
Number of subjects: 23
Study 32380894 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol fumarate metered dose inhaler (FF MDI) 9.6 μg
Number of subjects: 23
Study 36008598 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 367
Study 36008598 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 367
Study 33932031 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir (875 mg orally twice daily)
Number of subjects: 13
Study 33932031 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir (1250 mg orally twice daily)
Number of subjects: 13
Study 33932031 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir with concurrent CRT
Number of subjects: 13
Study 33932031 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir
Number of subjects: 13
Study 33932031 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir and CRT
Number of subjects: 13
Study 32057373 — intervention group
Group type: EXPERIMENTAL
Intervention: Bare-metal stents (BMS)
Number of subjects: 25032
Study 32057373 — intervention group
Group type: EXPERIMENTAL
Intervention: First-generation drug-eluting stents (DES1)
Number of subjects: 25032
Study 32057373 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation drug-eluting stents (DES2)
Number of subjects: 25032
Study 32057373 — intervention group
Group type: EXPERIMENTAL
Intervention: All stent types
Number of subjects: 25032
Study 34915485 — intervention group
Group type: EXPERIMENTAL
Intervention: APF-gel application (1.23% F applied for 4 min)
Number of subjects: 68
Study 34915485 — intervention group
Group type: EXPERIMENTAL
Intervention: FV application (Duraphat®, 2.26% F) for 24 h
Number of subjects: 68
Study 34915485 — intervention group
Group type: EXPERIMENTAL
Intervention: FV application (Duraphat®, 2.26% F) for 4 h
Number of subjects: 68
Study 34915485 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 68
Study 32217876 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurally adjusted ventilatory assist (n = 47)
Number of subjects: 99
Study 32217876 — intervention group
Group type: COMPARATOR
Intervention: Pressure support ventilation (n = 52)
Number of subjects: 99
Study 36189647 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol + Vasoactive
Number of subjects: 146
Study 36189647 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Vasoactive
Number of subjects: 146
Study 32677124 — intervention group
Group type: EXPERIMENTAL
Intervention: Story reading
Number of subjects: 292
Study 32677124 — intervention group
Group type: EXPERIMENTAL
Intervention: Video watching
Number of subjects: 292
Study 32677124 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 292
Study 32678131 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyelid hygiene performed twice a day for 10 days from 3 days before to 1 week after cataract surgery
Number of subjects: 69
Study 32678131 — intervention group
Group type: COMPARATOR
Intervention: Control group (no eyelid hygiene)
Number of subjects: 69
Study 34964652 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal bevacizumab (Group-1)
Number of subjects: 67
Study 34964652 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab combined with dexamethasone (Group-2)
Number of subjects: 67
Study 36141578 — intervention group
Group type: EXPERIMENTAL
Intervention: Dia‐Empower program
Number of subjects: 0
Study 36141578 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32431251 — intervention group
Group type: EXPERIMENTAL
Intervention: PROPER intervention (structured and repeated multidisciplinary medication review, supported by education and continuous evaluation)
Number of subjects: 380
Study 32431251 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 380
Study 32431251 — intervention group
Group type: EXPERIMENTAL
Intervention: PROPER intervention
Number of subjects: 380
Study 32431251 — intervention group
Group type: COMPARATOR
Intervention: PROPER intervention and Usual care
Number of subjects: 380
Study 36307616 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser treatment
Number of subjects: 20
Study 36307616 — intervention group
Group type: COMPARATOR
Intervention: Sclerotherapy (injections of ethanolamine oleate)
Number of subjects: 20
Study 32852613 — intervention group
Group type: EXPERIMENTAL
Intervention: Emixustat hydrochloride (daily oral doses ranging from 5 to 40 mg for 84 days)
Number of subjects: 23
Study 32852613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 32852613 — intervention group
Group type: EXPERIMENTAL
Intervention: Emixustat hydrochloride
Number of subjects: 23
Study 32678026 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma Medical Home (TMH) intervention
Number of subjects: 430
Study 32678026 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 430
Study 35399053 — intervention group
Group type: COMPARATOR
Intervention: 200 IU/d vitamin D3 (control dose)
Number of subjects: 688
Study 35399053 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/d vitamin D3
Number of subjects: 688
Study 35399053 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU/d vitamin D3
Number of subjects: 688
Study 33439433 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-ended response format
Number of subjects: 78
Study 33439433 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-choice response format
Number of subjects: 78
Study 33439433 — intervention group
Group type: EXPERIMENTAL
Intervention: Retell response format
Number of subjects: 78
Study 33439433 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative text genre
Number of subjects: 78
Study 33439433 — intervention group
Group type: EXPERIMENTAL
Intervention: Expository text genre
Number of subjects: 78
Study 33439433 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalizability studies
Number of subjects: 78
Study 33439433 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision studies projecting dependability
Number of subjects: 78
Study 32871913 — intervention group
Group type: EXPERIMENTAL
Intervention: External lumbar drainage (ELD)
Number of subjects: 100
Study 32871913 — intervention group
Group type: COMPARATOR
Intervention: Lumbar puncture (LP)
Number of subjects: 100
Study 35914511 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin + Ticagrelor
Number of subjects: 628
Study 35914511 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin + Clopidogrel
Number of subjects: 628
Study 33734418 — intervention group
Group type: EXPERIMENTAL
Intervention: BAILAMOS dance program
Number of subjects: 14
Study 33734418 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 14
Study 33200813 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (35 mg b.i.d.) on top of standard medical therapy
Number of subjects: 45
Study 33200813 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacotherapy
Number of subjects: 45
Study 33617369 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard table DAA approach under an early discharge protocol
Number of subjects: 239
Study 36267666 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary spinal cord stimulation (SCS)
Number of subjects: 44
Study 36267666 — intervention group
Group type: COMPARATOR
Intervention: Pulsed radiofrequency (PRF)
Number of subjects: 44
Study 34078209 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual interference group who putted at varied putting distances and had varied repetitive weekly schedule patterns
Number of subjects: 42
Study 34078209 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential learning group who putted at multiple putting distances, putting amplitudes, and putting movements with no repetitions
Number of subjects: 42
Study 34078209 — intervention group
Group type: EXPERIMENTAL
Intervention: Identical differential learning as in (b) except that participants also varied the putter
Number of subjects: 42
Study 34078209 — intervention group
Group type: COMPARATOR
Intervention: Control group who experienced no practice variations
Number of subjects: 42
Study 36448744 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Jessner solution
Number of subjects: 40
Study 36448744 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional steroid
Number of subjects: 40
Study 36448744 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 40
Study 33029953 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 × 30‐mg tablets
Number of subjects: 24
Study 33029953 — intervention group
Group type: COMPARATOR
Intervention: 4 × 30‐mg tablets as slurry
Number of subjects: 24
Study 33029953 — intervention group
Group type: COMPARATOR
Intervention: High-calorie/high-fat diet
Number of subjects: 24
Study 33478294 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 48
Study 33478294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 33063273 — intervention group
Group type: EXPERIMENTAL
Intervention: Plenadren (once-daily dual-release hydrocortisone)
Number of subjects: 30
Study 33063273 — intervention group
Group type: COMPARATOR
Intervention: Conventional hydrocortisone
Number of subjects: 30
Study 36115321 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone administration (single dose)
Number of subjects: 140
Study 36115321 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 140
Study 32106877 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mL pleural lavage fluid
Number of subjects: 400
Study 32106877 — intervention group
Group type: COMPARATOR
Intervention: 3000 mL pleural lavage fluid
Number of subjects: 400
Study 34800061 — intervention group
Group type: EXPERIMENTAL
Intervention: Significant others' collateral PTSD reports
Number of subjects: 394
Study 34800061 — intervention group
Group type: EXPERIMENTAL
Intervention: Veterans' self-reported PTSD symptoms
Number of subjects: 394
Study 34800061 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender composition of the couple
Number of subjects: 394
Study 34800061 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory subgroup analyses
Number of subjects: 394
Study 32444880 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe disease (defined as admission to the intensive care unit or death)
Number of subjects: 105
Study 32444880 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 105
Study 32444880 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality rate
Number of subjects: 105
Study 34969428 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication event reminder monitor system (MERM) with treatment monitor
Number of subjects: 106
Study 34969428 — intervention group
Group type: COMPARATOR
Intervention: Usual strategy (control group)
Number of subjects: 106
Study 34281997 — intervention group
Group type: EXPERIMENTAL
Intervention: Care management + portal
Number of subjects: 303
Study 34281997 — intervention group
Group type: COMPARATOR
Intervention: Portal alone
Number of subjects: 303
Study 33781008 — intervention group
Group type: EXPERIMENTAL
Intervention: Iberet Folic®
Number of subjects: 130
Study 33781008 — intervention group
Group type: COMPARATOR
Intervention: Zincofer®
Number of subjects: 130
Study 33781008 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study 34793244 — intervention group
Group type: EXPERIMENTAL
Intervention: Black caregivers
Number of subjects: 722
Study 34793244 — intervention group
Group type: EXPERIMENTAL
Intervention: White caregivers
Number of subjects: 722
Study 34793244 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 722
Study 34793244 — intervention group
Group type: COMPARATOR
Intervention: Multiple regression analyses
Number of subjects: 722